Learning Center
Evidence-based dosing, monitoring, and pharmacogenomics reference for therapeutic peptides. Curated from The Complete Peptide Protocol Guide (2026 Edition).
Download the full protocol guide (PDF)What Are Peptides?
Peptides are short chains of amino acids, typically containing between 2 and 50 amino acid residues. They are the building blocks of proteins and play crucial roles in biological processes. Unlike proteins, peptides are smaller and can be synthesized more easily, making them valuable tools in biomedical research.
Peptide Research Applications
Peptides are studied across numerous research domains including tissue repair, metabolic regulation, cognitive enhancement, anti-aging, and immune modulation. Their specificity and low toxicity profiles make them attractive candidates for therapeutic research.
How to Read the Evidence Grades
Strong Evidence
Large RCTs, FDA-approved indications, robust human data.
Moderate Evidence
Phase 2/3 trials with meaningful results; moderate human evidence.
Early / Mixed
Early human data, small trials, mixed results, or off-label extrapolation.
Preclinical
Preclinical only (animal/cell studies). No controlled human trials.
Regulatory Status Badges
Approved for at least one indication. Prescription required.
In pivotal trials. Not yet approved. Clinical trial access only.
Legal to compound at 503A/503B pharmacies with a prescription.
Not approved for human use. Available as a research chemical.
Understanding Peptide Stacking
Peptide stacking involves combining two or more peptides to achieve synergistic research outcomes. By selecting peptides with complementary mechanisms of action, researchers can target multiple pathways simultaneously. The key considerations include compatibility between peptides, timing of administration, and the specific research goals being pursued. Explore the Stack Synergy Matrix for proven combinations and pairings to avoid.